Sanofi’s potential eczema blockbuster Dupixent has got off to a strong start amid shrinking revenues in its diabetes business. Novo Nordisk posted Q3 results yesterday showing mounting sales for ...

Researchers have also found a higher incidence of heart disease, high blood pressure, stroke and diabetes, although they aren’t sure what the connection is between these conditions and eczema. As ...

thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity in the eczema market. While Lilly's stock looks expensive ...

It also helps in diabetes as the phenolic acid improves ... It is also considered beneficial for eczema and sunburns. As it also contains bioflavonoids this helps with hair growth, thickening ...